SEC Form 4 research
| Issuer | Phio Pharmaceuticals Corp. |
|---|---|
| Tickers | RXII, PHIO |
| Reporting owners | 20 |
| Officers and directors | 7 |
| Last public filing | 2026-09-30 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-30 | 2026-09-29 | Plott Ronald Todd | P | 5,000 | $1.04 | Not reported |
| 2026-09-30 | 2026-09-28 | Plott Ronald Todd | P | 5,000 | $1.03 | Not reported |
| 2026-09-29 | 2026-09-28 | Carson Lisa Cabott | A | 108,000 | $0 | Not reported |
| 2026-09-29 | 2026-09-28 | Bitterman Robert J | A | 400,000 | $0 | Not reported |
| 2026-09-29 | 2026-09-28 | Plott Ronald Todd | A | 17,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-24 | BRADFORD PATRICIA A | P | 6,500 | $1.01 | Not reported |
| 2026-09-23 | 2026-09-22 | Bitterman Robert J | P | 2,000 | $1.03 | Not reported |
| 2026-09-16 | 2026-09-15 | BRADFORD PATRICIA A | P | 12,000 | $1.03 | Not reported |
| 2026-08-20 | 2026-08-19 | Plott Ronald Todd | P | 15,000 | $1.14 | Not reported |
| 2026-08-19 | 2026-08-18 | Bitterman Robert J | P | 10,000 | $1.06 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.